Training Nigerian Female Radiologists to Perform Ultrasound-Guided Breast Biopsies for Breast Cancer Diagnosis Using Mobile Health Technology

What this Trial Is About

Researchers are evaluating a training program for Nigerian radiologists to perform ultrasound-guided breast biopsies using mobile health mHealth devices. This approach aims to create a practical and sustainable method to integrate ultrasound-guided biopsies into clinical practice for women with suspicious breast masses. The study focuses on improving diagnostic accuracy compared to current biopsy methods used in Nigerian hospitals. Women with a solid breast mass detected by ultrasound and suspected of breast cancer are included in the study. Instead of the usual blind biopsy or surgical excision, participants will receive an ultrasound-guided breast biopsy performed by a trained radiologist using the mHealth technology. This method is considered the standard of care in the United States due to its improved accuracy. Participants will be assessed based on the number of successful ultrasound-guided breast biopsies within one year. The study involves monitoring the biopsy procedures and outcomes to evaluate the training programs effectiveness. The study runs from September 2022 to September 2027 and is sponsored by Memorial Sloan Kettering Cancer Center.

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)